Hematological Malignancies

Trend in cumulative incidence* of lung cancer by period of treatment and sex in 5 year HL survivors (n=3,905) and the general population

pHR 0.35 (95%CI 0.16-0.78) 1990-2000 versus 1965-1979 adjusted for age males, follow-up<20years ♂

pHR 3.23 (95%CI 0.85-12.29) 1990-2000 versus 1965-1979 adjusted for age females, follow-up<20years ♀